Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
Manolo D’Arcangelo,1,2 Federico Cappuzzo2 1Cancer Center, University of Colorado, Aurora (CO), USA; 2Department of Oncology, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy Abstract: Lung cancer treatment has rapidly changed in the last few years thanks to novel insights into...
Enregistré dans:
Auteurs principaux: | D'Arcangelo M, Cappuzzo F |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4b23c5be47f34ac981950e6910814146 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical and comparative utility of afatinib in non-small cell lung cancer
par: D'Arcangelo M, et autres
Publié: (2014) -
Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
par: Stasi I, et autres
Publié: (2014) -
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
par: William Boland, et autres
Publié: (2010) -
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
par: Chad A Reade, et autres
Publié: (2009) -
Non-small cell lung cancer: the era of targeted therapy
par: Antonoff MB, et autres
Publié: (2012)